- Report
- February 2023
- 111 Pages
North America
From €3073EUR$3,450USD£2,658GBP
- Report
- February 2023
- 135 Pages
Asia Pacific
From €3073EUR$3,450USD£2,658GBP
- Report
- February 2023
- 126 Pages
Europe
From €3073EUR$3,450USD£2,658GBP
- Report
- February 2025
- 167 Pages
Japan
From €2227EUR$2,500USD£1,926GBP
- Report
- August 2024
- 184 Pages
Global
From €2227EUR$2,500USD£1,926GBP
- Report
- June 2024
- 148 Pages
Global
From €2227EUR$2,500USD£1,926GBP
- Report
- February 2024
- 150 Pages
Global
From €2227EUR$2,500USD£1,926GBP
- Report
- November 2023
- 166 Pages
Global
From €2227EUR$2,500USD£1,926GBP
- Report
- June 2025
- 250 Pages
India
From €2484EUR$2,789USD£2,149GBP
- Report
- June 2025
- 250 Pages
Saudi Arabia
From €2484EUR$2,789USD£2,149GBP
- Report
- June 2025
- 250 Pages
Mexico
From €2484EUR$2,789USD£2,149GBP
- Report
- June 2025
- 250 Pages
Vietnam
From €2484EUR$2,789USD£2,149GBP
- Report
- June 2025
- 250 Pages
Brazil
From €2484EUR$2,789USD£2,149GBP
- Report
- June 2025
- 250 Pages
Japan
From €2484EUR$2,789USD£2,149GBP
- Report
- May 2024
- 160 Pages
Global
From €4408EUR$4,949USD£3,813GBP
- Report
- November 2023
- 160 Pages
Global
From €3206EUR$3,599USD£2,773GBP
- Report
- November 2023
- 160 Pages
Global
From €3206EUR$3,599USD£2,773GBP
- Report
- October 2023
- 140 Pages
Global
From €3206EUR$3,599USD£2,773GBP
- Report
- September 2023
- 140 Pages
Global
From €3206EUR$3,599USD£2,773GBP
- Report
- September 2023
- 140 Pages
Global
From €3206EUR$3,599USD£2,773GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more